These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 20167603)

  • 21. Protein phosphatase PPM1B inhibits DYRK1A kinase through dephosphorylation of pS258 and reduces toxic tau aggregation.
    Lee YH; Im E; Hyun M; Park J; Chung KC
    J Biol Chem; 2021; 296():100245. PubMed ID: 33380426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications.
    Abbassi R; Johns TG; Kassiou M; Munoz L
    Pharmacol Ther; 2015 Jul; 151():87-98. PubMed ID: 25795597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.
    Zannini L; Buscemi G; Kim JE; Fontanella E; Delia D
    J Mol Cell Biol; 2012 Oct; 4(5):294-303. PubMed ID: 22735644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4.
    Sitz JH; Baumgärtel K; Hämmerle B; Papadopoulos C; Hekerman P; Tejedor FJ; Becker W; Lutz B
    Neuroscience; 2008 Dec; 157(3):596-605. PubMed ID: 18938227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neprilysin Is Suppressed by Dual-Specificity Tyrosine-Phosphorylation Regulated Kinase 1A (DYRK1A) in Down-Syndrome-Derived Fibroblasts.
    Kawakubo T; Mori R; Shirotani K; Iwata N; Asai M
    Biol Pharm Bull; 2017; 40(3):327-333. PubMed ID: 28250274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel inhibitor rescues cerebellar defects in a zebrafish model of Down syndrome-associated kinase Dyrk1A overexpression.
    Buchberger A; Schepergerdes L; Flaßhoff M; Kunick C; Köster RW
    J Biol Chem; 2021 Jul; 297(1):100853. PubMed ID: 34090874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice.
    Mazur-Kolecka B; Golabek A; Kida E; Rabe A; Hwang YW; Adayev T; Wegiel J; Flory M; Kaczmarski W; Marchi E; Frackowiak J
    J Neurosci Res; 2012 May; 90(5):999-1010. PubMed ID: 22252917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease.
    Ryoo SR; Jeong HK; Radnaabazar C; Yoo JJ; Cho HJ; Lee HW; Kim IS; Cheon YH; Ahn YS; Chung SH; Song WJ
    J Biol Chem; 2007 Nov; 282(48):34850-7. PubMed ID: 17906291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DYRK1A autophosphorylation on serine residue 520 modulates its kinase activity via 14-3-3 binding.
    Alvarez M; Altafaj X; Aranda S; de la Luna S
    Mol Biol Cell; 2007 Apr; 18(4):1167-78. PubMed ID: 17229891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of DYRK1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome.
    Hijazi M; Fillat C; Medina JM; Velasco A
    Exp Neurol; 2013 Jan; 239():229-34. PubMed ID: 23124096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases.
    Becker W; Weber Y; Wetzel K; Eirmbter K; Tejedor FJ; Joost HG
    J Biol Chem; 1998 Oct; 273(40):25893-902. PubMed ID: 9748265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Function and regulation of Dyrk1A: towards understanding Down syndrome.
    Park J; Song WJ; Chung KC
    Cell Mol Life Sci; 2009 Oct; 66(20):3235-40. PubMed ID: 19685005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity.
    Kim EJ; Kho JH; Kang MR; Um SJ
    Mol Cell; 2007 Oct; 28(2):277-90. PubMed ID: 17964266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleolar protein NOC4L inhibits tumorigenesis and progression by attenuating SIRT1-mediated p53 deacetylation.
    Jia X; Liu H; Ren X; Li P; Song R; Li X; Guo Y; Li X
    Oncogene; 2022 Sep; 41(39):4474-4484. PubMed ID: 36030331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A high-performance liquid chromatography assay for Dyrk1a, a Down syndrome-associated kinase.
    Bui LC; Tabouy L; Busi F; Dupret JM; Janel N; Planque C; Delabar JM; Rodrigues-Lima F; Dairou J
    Anal Biochem; 2014 Mar; 449():172-8. PubMed ID: 24374000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Form of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A nonphosphorylated at tyrosine 145 and 147 is enriched in the nuclei of astroglial cells, adult hippocampal progenitors, and some cholinergic axon terminals.
    Kida E; Walus M; Jarząbek K; Palminiello S; Albertini G; Rabe A; Hwang YW; Golabek AA
    Neuroscience; 2011 Nov; 195():112-27. PubMed ID: 21878370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Truncated Dyrk1A aggravates neuronal apoptosis by inhibiting ASF-mediated Bcl-x exon 2b inclusion.
    Zhang S; Zhong J; Xu L; Wu Y; Xu J; Shi J; Gu Z; Li X; Jin N
    CNS Neurosci Ther; 2024 Apr; 30(4):e14493. PubMed ID: 37864462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.
    Kimura R; Kamino K; Yamamoto M; Nuripa A; Kida T; Kazui H; Hashimoto R; Tanaka T; Kudo T; Yamagata H; Tabara Y; Miki T; Akatsu H; Kosaka K; Funakoshi E; Nishitomi K; Sakaguchi G; Kato A; Hattori H; Uema T; Takeda M
    Hum Mol Genet; 2007 Jan; 16(1):15-23. PubMed ID: 17135279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CK2 is the regulator of SIRT1 substrate-binding affinity, deacetylase activity and cellular response to DNA-damage.
    Kang H; Jung JW; Kim MK; Chung JH
    PLoS One; 2009 Aug; 4(8):e6611. PubMed ID: 19680552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming.
    Ong ALC; Ramasamy TS
    Ageing Res Rev; 2018 May; 43():64-80. PubMed ID: 29476819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.